Clinical Trial Update: Treatment for Subjects With Active Rheumatoid Arthritis (RA) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update from Amgen evaluating a treatment for active rheumatoid arthritis. The study status is completed, and no efficacy or safety result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED